Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Northrop Grumman Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
The Cigna Group April 22, 202699.0%
-
The Cigna Group April 22, 202599.4%
-
The Cigna Group April 24, 202498.8%
-
Northrop Grumman Corporation May 17, 202398.7%
-
The Cigna Group April 26, 202399.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Northrop Grumman Corporation | Grant or award | +349 | $552.17 | $192,707 |
| Apr 22, 2026 | The Cigna Group | Grant or award | +782 | — | — |
| Dec 11, 2025 | KKR & Co. Inc. | Grant or award | +1,605 | — | — |
| May 21, 2025 | Northrop Grumman Corporation | Grant or award | +385 | $473.90 | $182,452 |
| Apr 23, 2025 | The Cigna Group | Grant or award | +638 | — | — |
| Dec 12, 2024 | KKR & Co. Inc. | Grant or award | +1,238 | — | — |
| Jul 31, 2024 | Northrop Grumman Corporation | Grant or award | +377 | $484.32 | $182,589 |
| Apr 24, 2024 | The Cigna Group | Grant or award | +539 | — | — |
| Oct 2, 2023 | KKR & Co. Inc. | Grant or award | +3,029 | — | — |
| May 17, 2023 | Northrop Grumman Corporation | Grant or award | +392 | $447.34 | $175,357 |
| Apr 26, 2023 | The Cigna Group | Grant or award | +765 | — | — |
| Mar 15, 2023 | Northrop Grumman Corporation | Grant or award | +69 | $448.90 | $30,974 |
Questions about Kimberly A. Ross
What boards is Kimberly A. Ross on?
Kimberly A. Ross sits on the boards of KKR & Co. Inc., Northrop Grumman Corporation and The Cigna Group.
How long has Kimberly A. Ross served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.